TSX open
Loading markets…

Advertisement

Stocks/NASDAQ/NVNWF

Nvni Group Limited (NVNWF : NASDAQ)

Common Stock

$0.00

USD

+0.00 (193.75%)

Last updated: 2026-10-23

Follow NVNWF

NVNWF

Nvni Group Limited

Source:WealthAwesomeWealthAwesome
↓ $0.01 (-53.00%)
4 day period
$0.00$0.01$0.01Oct 9Oct 22Oct 23

Performance

1 Day

+193.75%

1 Week

-53.00%

1 Month

-

YTD

-53.00%

Key Statistics

Market Cap

-

52W High

$0.02

52W Low

$0.00

P/E Ratio

-

50 Day MA

$0.00

200 Day MA

$0.00

Beta

-0.10

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↑Above 50 SMA

Price vs 200-Day SMA

↑Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/23/2026$0.00$0.00$0.00$0.00$0.00100
10/22/2026$0.00$0.00$0.00$0.00$0.0020,489
10/12/2026$0.01$0.01$0.01$0.01$0.01100
10/9/2026$0.00$0.01$0.00$0.01$0.0155,247

About Nvni Group Limited

Nvni Group Limited, through its subsidiaries, operates in business-to-business software as a service (SaaS) market in Brazil and Latin America. It provides software subscription and licensing services, in which clients have access to software on multiple devices simultaneously; maintenance services, including technical support and technological evolution; and cloud computing, client, data analytics, and other services. Nvni Group Limited is headquartered in São Paulo, Brazil.

Financials

Revenue (TTM)
$196.00M
EBITDA
$33.73M
Profit Margin
-35.99%
ROE (TTM)
0.00%
EPS (Diluted)
0.00
Book Value
-2.66

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About NVNWF.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
SBFMSunshine Biopharma Inc$3.00+1696.41%
HCTIHealthcare Triangle Inc$6.71+1672.79%
PPCBPropanc Biopharma, Inc. Common Stock$2.80+921.90%
BDRXBiodexa Pharmaceticals$3.39+717.97%
RITRFReitar Logtech Holdings Limited$0.03+78.57%
CLROClearOne Inc$3.25+69.27%
BOLTBolt Biotherapeutics$6.27+49.64%
ESLAEstrella Immunopharma Inc.$0.98+35.53%

Advertisement